Millennium Pharmacon International Cash Flow Conversion Efficiency
Millennium Pharmacon International cash flow conversion efficiency. Based on the latest financial reports, Millennium Pharmacon International (SDPC) has a cash flow conversion efficiency ratio of -0.063x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.67 Billion ≈ $-1.09 Million USD) by net assets (Rp296.69 Billion ≈ $17.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Millennium Pharmacon International (2004–2024)
Cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024. This chart illustrates how Millennium Pharmacon International's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Millennium Pharmacon International share price for real-time trading data and today's change.
Millennium Pharmacon International Cash Flow Conversion Ratio Explained
Millennium Pharmacon International cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Millennium Pharmacon International Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Millennium Pharmacon International ranked by their cash flow conversion efficiency. Also see Millennium Pharmacon International (SDPC) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Energys Group Limited Ordinary Shares
NASDAQ:ENGS
|
N/A |
|
OYAK Yatirim Ortakligi AS
IS:OYAYO
|
-0.012x |
|
Shanghai Supezet Engineering Technology Corp Ltd
SHG:688121
|
-0.016x |
|
CEKD Bhd
KLSE:0238
|
0.024x |
|
Vision Sigma
TA:VISN
|
-0.017x |
|
Triton Holding Public Company Limited
BK:TRITN
|
-0.010x |
|
Donegal Investment Group PLC
IR:DQ7A
|
-0.234x |
|
Magnum Mining and Exploration Ltd
AU:MGU
|
-0.164x |
Annual Cash Flow Conversion Efficiency for Millennium Pharmacon International (2004–2024)
The table below shows the annual cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024. Review Millennium Pharmacon International free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp282.50 Billion ≈ $16.55 Million |
Rp-125.45 Billion ≈ $-7.35 Million |
-0.444x | -34.56% |
| 2023-12-31 | Rp277.71 Billion ≈ $16.27 Million |
Rp-91.65 Billion ≈ $-5.37 Million |
-0.330x | -308.43% |
| 2022-12-31 | Rp258.91 Billion ≈ $15.17 Million |
Rp41.00 Billion ≈ $2.40 Million |
0.158x | +306.44% |
| 2021-12-31 | Rp236.98 Billion ≈ $13.89 Million |
Rp-18.18 Billion ≈ $-1.07 Million |
-0.077x | -124.52% |
| 2020-12-31 | Rp229.20 Billion ≈ $13.43 Million |
Rp71.69 Billion ≈ $4.20 Million |
0.313x | +391.54% |
| 2019-12-31 | Rp235.44 Billion ≈ $13.80 Million |
Rp-25.26 Billion ≈ $-1.48 Million |
-0.107x | -627.27% |
| 2018-12-31 | Rp232.11 Billion ≈ $13.60 Million |
Rp4.72 Billion ≈ $276.75K |
0.020x | -2.94% |
| 2017-12-31 | Rp212.61 Billion ≈ $12.46 Million |
Rp4.46 Billion ≈ $261.18K |
0.021x | +111.13% |
| 2016-12-31 | Rp143.28 Billion ≈ $8.40 Million |
Rp-26.99 Billion ≈ $-1.58 Million |
-0.188x | +63.20% |
| 2015-12-31 | Rp134.31 Billion ≈ $7.87 Million |
Rp-68.74 Billion ≈ $-4.03 Million |
-0.512x | -1218.86% |
| 2014-12-31 | Rp121.79 Billion ≈ $7.14 Million |
Rp-4.73 Billion ≈ $-276.93K |
-0.039x | +91.69% |
| 2013-12-31 | Rp114.87 Billion ≈ $6.73 Million |
Rp-53.67 Billion ≈ $-3.14 Million |
-0.467x | -2326.94% |
| 2012-12-31 | Rp104.62 Billion ≈ $6.13 Million |
Rp2.19 Billion ≈ $128.61K |
0.021x | +118.58% |
| 2011-12-31 | Rp94.78 Billion ≈ $5.55 Million |
Rp-10.70 Billion ≈ $-626.92K |
-0.113x | -273.40% |
| 2007-12-31 | Rp70.24 Billion ≈ $4.12 Million |
Rp4.57 Billion ≈ $267.94K |
0.065x | +391.77% |
| 2006-12-31 | Rp60.63 Billion ≈ $3.55 Million |
Rp802.62 Million ≈ $47.03K |
0.013x | -78.04% |
| 2004-12-31 | Rp45.18 Billion ≈ $2.65 Million |
Rp2.72 Billion ≈ $159.57K |
0.060x | -- |
About Millennium Pharmacon International
PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more